MarketPulse
I

$IXJ

1 article found
0 positive
0 negative
1 neutral
The Motley FoolThe Motley Fool··Sara Appino

GLP-1 Boom Powers U.S. Pharma ETF Past Global Rival

U.S. pharma ETF IHE surged 39.70% on GLP-1 drug success while global healthcare ETF IXJ gained 10%, highlighting concentration versus diversification tradeoffs.
JNJABBVLLYIHEIXJportfolio concentrationGLP-1 drugs